Related references
Note: Only part of the references are listed.Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
Rudolf Uher
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
Distinguishing true from false positives in genomic studies: p values
Linda Broer et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2013)
Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D
Chiara Fabbri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
A genome-wide association study of a sustained pattern of antidepressant response
Aimee M. Hunter et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule
H. Zhang et al.
MOLECULAR PSYCHIATRY (2013)
TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression
Barbara Arias et al.
NEUROPSYCHOBIOLOGY (2013)
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets'
Annamaria Cattaneo et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder
R. H. Perlis et al.
PHARMACOGENOMICS JOURNAL (2013)
Serotonin transporter genotype and function in relation to antidepressant response in Koreans
Woojae Myung et al.
PSYCHOPHARMACOLOGY (2013)
RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis
A. Ferres-Coy et al.
TRANSLATIONAL PSYCHIATRY (2013)
Beware of risk for increased false positive rates in genome-wide association studies for phenotypic variability
Xia Shen et al.
Frontiers in Genetics (2013)
Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice
Justin S. Catches et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Does prior antidepressant treatment of major depression impact brain function during current treatment?
Aimee M. Hunter et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
Stefano Porcelli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Gene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation
Francesco Benedetti et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Early Response and Remission as Predictors of a Good Outcome of a Major Depressive Episode at 12-Month Follow-Up: A Prospective, Longitudinal, Observational Study
Antonio Ciudad et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Depression: an inflammatory illness?
Rajeev Krishnadas et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response
Zhi Xu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
Jessica A. Cutler et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Identification and functional characterization of three novel alleles for the serotonin transporter-linked polymorphic region
E. A. Ehli et al.
MOLECULAR PSYCHIATRY (2012)
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects
A. Bortolozzi et al.
MOLECULAR PSYCHIATRY (2012)
Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression
Alessandro Serretti et al.
NEUROPSYCHOBIOLOGY (2012)
BDNF Val66Met Impairs Fluoxetine-Induced Enhancement of Adult Hippocampus Plasticity
Kevin G. Bath et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Improving Power of Genome-Wide Association Studies with Weighted False Discovery Rate Control and Prioritized Subset Analysis
Wan-Yu Lin et al.
PLOS ONE (2012)
Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response
Y. Ji et al.
PHARMACOGENOMICS JOURNAL (2012)
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
Paolo Olgiati et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder
Concetta Crisafulli et al.
PSYCHIATRY RESEARCH (2012)
The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment
Yingcheng Wang et al.
PSYCHIATRY RESEARCH (2012)
Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D
S. L. Clark et al.
PSYCHOLOGICAL MEDICINE (2012)
Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis
Katherine E. Tansey et al.
PLOS MEDICINE (2012)
Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells
Y. S. Singh et al.
TRANSLATIONAL PSYCHIATRY (2012)
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D
D. E. Adkins et al.
TRANSLATIONAL PSYCHIATRY (2012)
GCTA: A Tool for Genome-wide Complex Trait Analysis
Jian Yang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial
Glyn Lewis et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
Ari Illi et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)
Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism
Stefano Porcelli et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder
Neslihan Aygun Kocabas et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Pathway-based analysis of GWAS datasets: effective but caution required
Peilin Jia et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study
D. Spronk et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response
Zhi Xu et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression
Alessandro Serretti et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Variation in GNB3 predicts response and adverse reactions to antidepressants
Robert Keers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies
S. I. Shyn et al.
MOLECULAR PSYCHIATRY (2011)
Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD
Merja Viikki et al.
NEUROSCIENCE LETTERS (2011)
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker
Ayelet Morag et al.
PHARMACOGENOMICS (2011)
BDNF Val66Met genotype and 6-month remission rates in late-life depression
W. D. Taylor et al.
PHARMACOGENOMICS JOURNAL (2011)
Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients
A. de Vos et al.
PHARMACOGENOMICS JOURNAL (2011)
Depression and antidepressants: Insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters
Britta Haenisch et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Genome-wide association studies of antidepressant outcome: A brief review
Gonzalo Laje et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes
Antonio Drago et al.
PROGRESS IN NEUROBIOLOGY (2011)
Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia
Alessandro Serretti et al.
PSYCHIATRY RESEARCH (2011)
TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients
Hsuan-Chi Wang et al.
PSYCHOPHARMACOLOGY (2011)
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR
Jana Strohmaier et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders
Alessandro Serretti et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
Andre Tadic
Neuropsychiatric Disease and Treatment (2011)
Genes, Environment, and Individual Differences in Responding to Treatment for Depression
Rudolf Uher
HARVARD REVIEW OF PSYCHIATRY (2011)
Rare Genotype Combination of the Serotonin Transporter Gene Associated With Treatment Response in Severe Personality Disorder
Nader Perroud et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2010)
Association of FKBP5 Polymorphisms With Suicidal Events in the Treatment of Resistant Depression in Adolescents (TORDIA) Study
David Brent et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Association of Polymorphisms in Genes Regulating the Corticotropin-Releasing Factor System With Antidepressant Treatment Response
Elisabeth B. Binder et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
The Interleukin 1 Beta (IL 1B) Gene Is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression
Bernhard T. Baune et al.
BIOLOGICAL PSYCHIATRY (2010)
Genome-Wide Association Scan of Trait Depression
Antonio Terracciano et al.
BIOLOGICAL PSYCHIATRY (2010)
Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients
Roy H. Perlis et al.
BIOLOGICAL PSYCHIATRY (2010)
Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
Matthew J. Taylor et al.
BIOLOGICAL PSYCHIATRY (2010)
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Holly A. Garriock et al.
BIOLOGICAL PSYCHIATRY (2010)
Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram
Salvador Fudio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
HTR2A gene variation is involved in antidepressant treatment response
Susanne Lucae et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine
F. Benedetti et al.
EUROPEAN PSYCHIATRY (2010)
Association of BDNF Val66Met Polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine
Yan-Feng Zou et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population
Taro Kishi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Debbie G. A. Janssen et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Magali Noro et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study
Neslihan Aygun Kocabas et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response
Katharina Domschke et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
DNA sequence variants of the FKBP5 gene are associated with unipolar depression
Astrid Zobel et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder
Mei Hung Chi et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
BDNF Val66met polymorphism, white matter abnormalities and remission of geriatric depression
George S. Alexopoulos et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder
Esteve Gudayol-Ferre et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Characterization of the Core Mammalian Clock Component, NPAS2, as a REV-ERBα/RORα Target Gene
Christine Crumbley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure
Yuyan Jin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The Association Between Serotonin 2C Receptor Polymorphisms and Weight Gain and Eating Behavior in Patients Using Mirtazapine A Prospective Follow-Up Study
Arne J. Risselada et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
α2-Adrenoceptor Blockade Accelerates the Neurogenic, Neurotrophic, and Behavioral Effects of Chronic Antidepressant Treatment
Sudhirkumar U. Yanpallewar et al.
JOURNAL OF NEUROSCIENCE (2010)
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
Wakako Umene-Nakano et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression
R. H. Kang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M. Kato et al.
MOLECULAR PSYCHIATRY (2010)
Population genetic study of the brain-derived neurotrophic factor (BDNF) gene
T. L. Petryshen et al.
MOLECULAR PSYCHIATRY (2010)
HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort
Taro Kishi et al.
NEUROMOLECULAR MEDICINE (2010)
Serotonin Transporter Gene Polymorphism Associated with Short-Term Treatment Response to Venlafaxine
Sang-Hyuk Lee et al.
NEUROPSYCHOBIOLOGY (2010)
Norepinephrine and Serotonin Transporter Genes: Impact on Treatment Response in Depression
Anna Baffa et al.
NEUROPSYCHOBIOLOGY (2010)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment
Sonja Horstmann et al.
NEUROPSYCHOPHARMACOLOGY (2010)
ABCB1 ( MDR1) polymorphisms and antidepressant response in geriatric depression
Jane E. Sarginson et al.
PHARMACOGENETICS AND GENOMICS (2010)
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response
Ming-Hsien Tsai et al.
PHARMACOGENOMICS (2010)
A novel 5-HT2A receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: Approaching early-onset antidepressants
Dilip Kumar Pandey et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder
Ari Illi et al.
PSYCHIATRY RESEARCH (2010)
Genetic polymorphisms in the treatment of depression: Speculations from an augmentation study using atomoxetine
Frederick Reimherr et al.
PSYCHIATRY RESEARCH (2010)
MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Anne Baudry et al.
SCIENCE (2010)
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes
Neslihan Aygun Kocabas et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Gender differences in antidepressant drug response
Robert Keers et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2010)
Genetic variation in microRNA networks: the implications for cancer research
Brid M. Ryan et al.
NATURE REVIEWS CANCER (2010)
SLC6A4 Variation and Citalopram Response
D. A. Mrazek et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Effect of 5-HT1A Gene Polymorphisms on Antidepressant Response in Major Depressive Disorder
Masaki Kato et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Jean-Martin Beaulieu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Novel Sequence Variations in the Brain-Derived Neurotrophic Factor Gene and Association With Major Depression and Antidepressant Treatment Response
Julio Licinio et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
Marcus Ising et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder
Roy H. Perlis et al.
BIOLOGICAL PSYCHIATRY (2009)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Association of the adrenergic alpha 2a receptor-1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder
Hwa-Young Lee et al.
BRAIN RESEARCH (2009)
Moderation of antidepressant response by the serotonin transporter gene
Patricia Huezo-Diaz et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Wei Zhang et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats
Megan E. Breuer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Eduard Maron et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients
Reiji Yoshimura et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives
Jeffrey R. Bishop et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
MAOA Gene polymorphisms and response to mirtazapine in major depression
Dong-Sheng Tzeng et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1
Anna Secher et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients
Shih-Jen Tsai et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Interaction between genetic polymorphisms and stressful life events in first episode depression
Jens Drachmann Bukh et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Venlafaxine Metabolism as a Marker of Cytochrome P450 Enzyme 2D6 Metabolizer Status
Alice I. Nichols et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans
C. Dong et al.
MOLECULAR PSYCHIATRY (2009)
Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
Rulun Zhou et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients
Roy H. Perlis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors
Barbara Arias et al.
PHARMACOGENETICS AND GENOMICS (2009)
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder
Henricus G. Ruhe et al.
PHARMACOGENETICS AND GENOMICS (2009)
Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response
Eric J. Peters et al.
PHARMACOGENETICS AND GENOMICS (2009)
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy
M. J. V. Wilkie et al.
PHARMACOGENOMICS JOURNAL (2009)
Genetic predictors of response to antidepressants in the GENDEP project
Rudolf Uher et al.
PHARMACOGENOMICS JOURNAL (2009)
Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response
Shih-Jen Tsai et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder
Eugene Lin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A
Sandra M. Villafuerte et al.
PSYCHIATRIC GENETICS (2009)
5-HTTLPR modulates antidepressant efficacy in depressed women
Florence Gressier et al.
PSYCHIATRIC GENETICS (2009)
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients
Masaki Kato et al.
PSYCHIATRY RESEARCH (2009)
Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder
Shih-Jen Tsai et al.
PSYCHIATRY RESEARCH (2009)
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
Francesco Benedetti et al.
PSYCHOPHARMACOLOGY (2009)
Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response
Wenjiao Min et al.
PSYCHOPHARMACOLOGY (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
The FKBP5-gene in depression and treatment response -: An association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort
Magnus Lekman et al.
BIOLOGICAL PSYCHIATRY (2008)
Serotonin transporter polymorphism and bleeding time during SSRI therapy
Dahlia M. C. Hougardy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
Keizo Yoshida et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea
Misuzu Tanaka et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response
M-L Wong et al.
MOLECULAR PSYCHIATRY (2008)
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression
Manfred Uhr et al.
NEURON (2008)
Serotonin receptor 1A-1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression?
B. T. Baune et al.
NEUROSCIENCE LETTERS (2008)
Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
Eric J. Peters et al.
PLOS ONE (2008)
Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment
Mladen Vassilev Tzvetkov et al.
PHARMACOGENETICS AND GENOMICS (2008)
Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics
Shih-Jen Tsai et al.
PHARMACOGENOMICS (2008)
Genetic variants in FKBP5 affecting response to antidepressant drug treatment
Julia Kirchheiner et al.
PHARMACOGENOMICS (2008)
Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder
S-J Tsai et al.
PHARMACOGENOMICS JOURNAL (2008)
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: A pilot study
Georg Nikisch et al.
PHARMACOLOGICAL RESEARCH (2008)
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Jean-Martin Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
Masaki Kato et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression
Katharina Domschke et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression
Alma Mihaljevic Peles et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients
Masaki Kato et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Serotonin transporter gene and response to lithium augmentation in depression
Thomas J. Stamm et al.
PSYCHIATRIC GENETICS (2008)
Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome
James J. Crowley et al.
PSYCHIATRIC GENETICS (2008)
The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients
Kim M. Smits et al.
PSYCHIATRIC GENETICS (2008)
Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder
Nada Bozina et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Serotonin transporter gene polymorphisms and sertraline response in major depression patients
Ozlem Dogan et al.
GENETIC TESTING (2008)
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders
M. Gratacos et al.
PHARMACOGENOMICS JOURNAL (2008)
Association of the COMT val158met variant with antidepressant treatment response in major depression
Bernhard T. Baune et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients
I. Rudberg et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study
Helen Lavretsky et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex
Joanna M. Wieronska et al.
BRAIN RESEARCH (2007)
Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment
Shih-Jen Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors
Alfred O. Berg et al.
GENETICS IN MEDICINE (2007)
Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment
Sergi Papiol et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta - 50T/C single nucleotide polymorphism
Mazda Adli et al.
BIOLOGICAL PSYCHIATRY (2007)
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression
Gonzalo Laje et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder
Rhee-Hun Kang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects
Joanna S. Fowler et al.
BIOLOGICAL PSYCHIATRY (2007)
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine
Keizo Yoshida et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort
Silvia Paddock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
David Nutt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression
Xian-Zhang Hu et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
P. K. Gillman
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton et al.
NATURE (2007)
Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors
Kim Smits et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder
Jun-ichi Iga et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression
Andre Tadic et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample
Jeffrey B. Kraft et al.
BIOLOGICAL PSYCHIATRY (2007)
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Jennifer L. Warner-Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders
Zhongchun Liu et al.
NEUROSCIENCE LETTERS (2007)
A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression
Murray J. V. Wilkie et al.
PHARMACOGENETICS AND GENOMICS (2007)
No gene is an island: The flip-flop phenomenon
Ping-I Lin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
J. Kirchheiner et al.
PHARMACOGENOMICS JOURNAL (2007)
Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population
Byung-Joo Ham et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression
Rhee-Hun Kang et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2007)
Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness
Gary M. Levin et al.
MOLECULAR DIAGNOSIS & THERAPY (2007)
Relationship between g-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression
Rhee-Hun Kang et al.
NEUROPSYCHOBIOLOGY (2007)
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression
Masaki Kato et al.
NEUROPSYCHOBIOLOGY (2007)
Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy
Chi-Un Pae et al.
PHARMACOGENETICS AND GENOMICS (2007)
Serotonin transporter gene variants and behavior: A comprehensive review
Alessandro Serretti et al.
CURRENT DRUG TARGETS (2006)
Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder
Myoung-Jin Choi et al.
BRAIN RESEARCH (2006)
Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
Jantien P. Brouwer et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression
Hyeran Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders
Younger W. -Y. Yu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine
M. E. E. Shams et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder
B. S. Pickard et al.
MOLECULAR PSYCHIATRY (2006)
Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects
Arvind Govindarajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Higher 5-HTIA receptor binding potential during a major depressive episode predicts poor treatment response:: Preliminary data from a naturalistic study
Rarnin V. Parsey et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities
Chee Hong Ng et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Sequence-based CYP2D6 genotyping in the Korean population
Soo-Youn Lee et al.
THERAPEUTIC DRUG MONITORING (2006)
Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries
MA Buist-Bouwman et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
The impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patients
M Ueda et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
ABCB1 (P-Glycoprotein/MDR1) gene G2677T/A sequence variation (polymorphism):: Lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline
B Laika et al.
CLINICAL CHEMISTRY (2006)
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder
XZ Hu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Polymorphisms of the glucocorticoid receptor gene and major depression
EFC van Rossum et al.
BIOLOGICAL PSYCHIATRY (2006)
Polymorphisms in the 5-hydroxytryptamine 2A receptor and cytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients
Y Suzuki et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: A critical overview
D Tardito et al.
PHARMACOLOGICAL REVIEWS (2006)
Serotonin transporter polymorphisms and side effects in antidepressant therapy - a pilot study
J Popp et al.
PHARMACOGENOMICS (2006)
Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citaolpram)
I Rudberg et al.
THERAPEUTIC DRUG MONITORING (2006)
Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin
B Arias et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder
CJ Hong et al.
PHARMACOGENOMICS JOURNAL (2006)
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients
Masaki Kato et al.
NEUROPSYCHOBIOLOGY (2006)
CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly
Ellen M. Whyte et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
JBJ Kwok et al.
ANNALS OF NEUROLOGY (2005)
No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population
BJ Ham et al.
PSYCHIATRIC GENETICS (2005)
Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine
MG Scordo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Association study of a Monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response
YWY Yu et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype
J van der Weide et al.
THERAPEUTIC DRUG MONITORING (2005)
Dopaminergic mechanism of antidepressant action in depressed patients
P Willner et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotionin transporter promoter polymorphism
M Kato et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder
SH Lee et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2005)
Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
B Arias et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression
A Szegedi et al.
PHARMACOGENOMICS JOURNAL (2005)
Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram
MJ Choi et al.
NEUROPSYCHOBIOLOGY (2005)
Clinical aspects of the MDRI (ABCB1) gene polymorphism
M Eichelbaum et al.
THERAPEUTIC DRUG MONITORING (2004)
Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions
A LLerena et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms
K Yoshida et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers
W Steimer et al.
CLINICAL CHEMISTRY (2004)
Investigation of serotonin-related genes in antidepressant response
EJ Peters et al.
MOLECULAR PSYCHIATRY (2004)
Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression
DH Overstreet et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders
A Serretti et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
The dysbindin gene in major depression:: An association study
P Zill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains
P Zill et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain:: regional differences
T Lifschytz et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
LK Durham et al.
PSYCHOPHARMACOLOGY (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
EB Binder et al.
NATURE GENETICS (2004)
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings
A Serretti et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans
J Licinio et al.
MOLECULAR PSYCHIATRY (2004)
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response
S Lemonde et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression
GM Murphy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment
MS Lee et al.
PSYCHIATRIC GENETICS (2004)
Serotonin transporter promoter and intron 2 polymorphisms: Relationship between allelic variants and gene expression
D Hranilovic et al.
BIOLOGICAL PSYCHIATRY (2004)
The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients
Y Suzuki et al.
PHARMACOGENOMICS JOURNAL (2004)
Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders
HJ Lee et al.
PHARMACOGENOMICS JOURNAL (2004)
Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine
K Sawamura et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The human phosphatidylinositol phosphatase SAC1 interacts with the coatomer I complex
HM Rohde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Age-dependent antidepressant pharmacogenomics:: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortriptyline
PR Joyce et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study
B Arias et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine
C Charlier et al.
THERAPEUTIC DRUG MONITORING (2003)
Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response
SJ Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19
BN Yu et al.
DRUG METABOLISM AND DISPOSITION (2003)
Pharmacogenetics of antidepressant medication intolerance
GM Murphy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Beta-1-adrenergic receptor gene in major depression:: Influence on antidepressant treatment response
P Zill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
SSRIs antidepressant activity is influenced by Gβ3 variants
A Serretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review
PA Seymour et al.
CNS DRUG REVIEWS (2003)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
RH Perlis et al.
BIOLOGICAL PSYCHIATRY (2003)
Monoamine oxidase a gene polymorphism, 5-HT2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine
K Yoshida et al.
NEUROPSYCHOBIOLOGY (2003)
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans
CB Eap et al.
PHARMACOGENETICS (2003)
Monoamine oxidase: A gene poly polymorphism and antidepressant orphism, tryptophan hydroxylase gene response to fluvoxamine in Japanese patients with major depressive disorder
K Yoshida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment
H Takahashi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2002)
A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine
K Ito et al.
PSYCHIATRY RESEARCH (2002)
Impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients
K Shimoda et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Moclobemide response in depressed patients:: Association study with a functional polymorphism in the monoamine oxidase A promoter
DJ Müller et al.
PHARMACOPSYCHIATRY (2002)
Initial conditions of serotonin transporter kinetics and genotype: Influence on SSRI treatment trial outcome
JL Rausch et al.
BIOLOGICAL PSYCHIATRY (2002)
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients
K Yoshida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders
YWY Yu et al.
MOLECULAR PSYCHIATRY (2002)
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
JH Krystal et al.
MOLECULAR PSYCHIATRY (2002)
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity
C Cusin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Association between-1438G/A promoter polymorphism in the 5-HT2A receptor gene and fluvoxamine response in Japanese patients with major depressive disorder
K Sato et al.
NEUROPSYCHOBIOLOGY (2002)
No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors
A Serretti et al.
PSYCHIATRY RESEARCH (2001)
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
CA Grimes et al.
PROGRESS IN NEUROBIOLOGY (2001)
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
A Serretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression
R Zanardi et al.
BIOLOGICAL PSYCHIATRY (2001)
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
A Serretti et al.
MOLECULAR PSYCHIATRY (2001)
CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants:: a first step towards subpopulation-specific dosages
J Kirchheiner et al.
ACTA PSYCHIATRICA SCANDINAVICA (2001)
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers
CB Eap et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Serotonin-2A-receptor and -transporter polymorphisms:: lack of association in patients with major depression
C Minov et al.
NEUROSCIENCE LETTERS (2001)
Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors
AM Crissman et al.
PSYCHOPHARMACOLOGY (2001)
The effect of paroxetine on 5-HT2A receptors in depression: An [F-18]setoperone PET imaging study
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Quantitative pharmacogenetics of nortriptyline - A novel approach
EE Kvist et al.
CLINICAL PHARMACOKINETICS (2001)
Association study of the 5-HT6 receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders
WH Wu et al.
NEUROPSYCHOBIOLOGY (2001)
Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
BG Pollock et al.
NEUROPSYCHOPHARMACOLOGY (2000)
The role of dopamine in the mechanism of action of antidepressant drugs
PS D'Aquila et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Evidence for an association between a G-protein β3-gene variant with depression and response to antidepressant treatment
P Zill et al.
NEUROREPORT (2000)
Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: Impact of CYP2D6 genotype on the hydroxylation of nortriptyline
S Morita et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers
EG Jönsson et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population
T Fukuda et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene
R Zanardi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Serotonin transporter gene polymorphism and antidepressant response
DK Kim et al.
NEUROREPORT (2000)
Share Paper
